These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18508540)

  • 41. Nucleic acid modulation of gene expression: approaches for nucleic acid therapeutics against cancer.
    Nakata Y; Kim TK; Shetzline S; Gewirtz AM
    Crit Rev Eukaryot Gene Expr; 2005; 15(2):163-82. PubMed ID: 16022634
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting Highly Structured RNA by Cooperative Action of siRNAs and Helper Antisense Oligomers in Living Cells.
    Dutkiewicz M; Ojdowska A; Kuczynski J; Lindig V; Zeichhardt H; Kurreck J; Ciesiołka J
    PLoS One; 2015; 10(8):e0136395. PubMed ID: 26308932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antisense strategies in degenerative joint diseases: sense or nonsense?
    Huber LC; Distler O; Gay RE; Gay S
    Adv Drug Deliv Rev; 2006 May; 58(2):285-99. PubMed ID: 16574269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Therapeutic oligonucleotides: a review].
    Wang X; Xian J; Chen G; Peng H
    Sheng Wu Gong Cheng Xue Bao; 2018 May; 34(5):664-675. PubMed ID: 29893074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-coding RNAs: Therapeutic Strategies and Delivery Systems.
    Ling H
    Adv Exp Med Biol; 2016; 937():229-37. PubMed ID: 27573903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liver as a target for oligonucleotide therapeutics.
    Sehgal A; Vaishnaw A; Fitzgerald K
    J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Types of RNA therapeutics.
    Goleij P; Babamohamadi M; Rezaee A; Sanaye PM; Tabari MAK; Sadreddini S; Arefnezhad R; Motedayyen H
    Prog Mol Biol Transl Sci; 2024; 203():41-63. PubMed ID: 38360005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro evaluation of antisense RNA efficacy against filovirus infection, by use of reverse genetics.
    Groseth A; Hoenen T; Alimonti JB; Zielecki F; Ebihara H; Theriault S; Ströher U; Becker S; Feldmann H
    J Infect Dis; 2007 Nov; 196 Suppl 2():S382-9. PubMed ID: 17940974
    [TBL] [Abstract][Full Text] [Related]  

  • 49. siRNA-based approaches in cancer therapy.
    Devi GR
    Cancer Gene Ther; 2006 Sep; 13(9):819-29. PubMed ID: 16424918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advances in therapeutic bacterial antisense biotechnology.
    Hegarty JP; Stewart DB
    Appl Microbiol Biotechnol; 2018 Feb; 102(3):1055-1065. PubMed ID: 29209794
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progress in the development of nucleic acid therapeutics for cancer.
    Kalota A; Shetzline SE; Gewirtz AM
    Cancer Biol Ther; 2004 Jan; 3(1):4-12. PubMed ID: 14726654
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.
    Xu L; Anchordoquy T
    J Pharm Sci; 2011 Jan; 100(1):38-52. PubMed ID: 20575003
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
    Mahato RI; Cheng K; Guntaka RV
    Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dermal/transdermal delivery of small interfering RNA and antisense oligonucleotides- advances and hurdles.
    Ita K
    Biomed Pharmacother; 2017 Mar; 87():311-320. PubMed ID: 28064104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antisense RNA gene therapy for studying and modulating biological processes.
    Weiss B; Davidkova G; Zhou LW
    Cell Mol Life Sci; 1999 Mar; 55(3):334-58. PubMed ID: 10228554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systemic delivery and pre-clinical evaluation of nanoparticles containing antisense oligonucleotides and siRNAs.
    Zhang C; Newsome JT; Mewani R; Pei J; Gokhale PC; Kasid UN
    Methods Mol Biol; 2009; 480():65-83. PubMed ID: 19085118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of Toll-like receptors in antisense and siRNA [corrected].
    Agrawal S; Kandimalla ER
    Nat Biotechnol; 2004 Dec; 22(12):1533-7. PubMed ID: 15583662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene therapy for HIV.
    Lever AM
    Sex Transm Infect; 2001 Apr; 77(2):93-6. PubMed ID: 11287684
    [No Abstract]   [Full Text] [Related]  

  • 59. Safety of antisense oligonucleotide and siRNA-based therapeutics.
    Chi X; Gatti P; Papoian T
    Drug Discov Today; 2017 May; 22(5):823-833. PubMed ID: 28159625
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antisense treatment of viral infection.
    Whitton JL
    Adv Virus Res; 1994; 44():267-303. PubMed ID: 7817875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.